Market evolution: Hydrazine and hydroxylamine derivatives (CN 2928) — 2015–2025

Introduction

Organic derivatives of hydrazine and hydroxylamine (CN 2928) are intermediate organic chemicals with applications across the pharmaceutical, agrochemical and industrial sectors. Over the 2015–2025 period, the European Union's trade position in this product class has undergone significant structural change. While the EU's total trade in CN 2928 remains substantial — with imports and exports collectively exceeding half a billion euros annually by 2025 — the trajectory reveals a deteriorating trade balance, a reorientation of supplier geography, and growing vulnerability to external supply disruptions. This report draws on EU-level trade data to identify and explain the principal dynamics that have shaped this market over the past decade.

A widening trade deficit fuelled by surging imports and eroding export volumes

The EU's trade balance in CN 2928 has deteriorated markedly

The EU has consistently been a net importer of hydrazine and hydroxylamine derivatives, but the deficit widened substantially between 2015 and 2025. The trade balance in value terms moved from –€108.5 million in 2015 to –€194.9 million in 2025, a decline of nearly 80% (General Overview). At its worst point, the deficit reached –€253.1 million (its minimum over the period), indicating that the early-to-mid 2020s represented a period of particularly acute import dependence.

Import growth has been driven by both volume and value increases

EU imports of CN 2928 grew from €305.7 million (15,082 tonnes) in 2015 to €380.0 million (18,000 tonnes) in 2025, corresponding to increases of +24.3% in value and +19.3% in quantity. The average import price edged up from €20,255/t to €21,095/t (+4.1%), suggesting that volume expansion, rather than price inflation, has been the primary driver of the rising import bill. Notably, both quantity and value peaked well above their 2025 levels: import volume reached a maximum of 26,962 tonnes and import value peaked at €448.9 million during the period, indicating a volatile trajectory with cyclical peaks and troughs.

EU exports have contracted in volume while unit values have risen

In contrast to the import trend, EU exports tell a story of declining competitiveness in volume terms. Export quantity fell from 5,879 tonnes in 2015 to 4,345 tonnes in 2025 (–26.1%), while export value declined more modestly from €197.2 million to €185.1 million (–6.2%). The partial offset comes from a steep rise in average export prices, which climbed from €33,467/t to €42,517/t (+27.0%) — and peaked at €53,413/t during the period. This price increase points toward a possible shift in the EU's export mix toward higher-value or more specialised derivatives, even as the overall volume footprint contracts.

A fundamental reorientation of the EU's supplier geography

Switzerland has consolidated its position as the dominant import partner

Switzerland is by far the EU's largest source of CN 2928 imports, accounting for €172.7 million in 2015 and €218.5 million in 2025 (+26.5%). The relationship is remarkably stable: the Herfindahl-Hirschman Index (HHI) for Swiss imports shows a coefficient of variation of only 0.11 — the lowest among the EU's major partners (Volatility & Shocks). Switzerland's dominance likely reflects the presence of major European-origin pharmaceutical and chemical firms that produce via Swiss-based entities, making this a structurally embedded trade relationship rather than a classical import dependence on a distant supplier.

India has emerged as a major import source with extreme price volatility

The most dramatic shift in the import landscape has been the rise of India. Indian imports grew from just €9.5 million in 2015 to €55.8 million in 2025 — a staggering increase of +486.3%. India peaked at €91.2 million during the period. However, this growth has been accompanied by significant price instability: the coefficient of variation for Indian imports stands at 0.67, and the data reveals a major price shock in 2019, with an abnormality score of 33,679 and a price shift of +573%, representing 35% of the import value share that year (Volatility & Shocks). This suggests either a sudden reclassification or a genuine supply disruption that caused a spike in unit costs.

The United States and United Kingdom have lost ground as EU suppliers

Two notable declines stand out. US imports into the EU fell from €40.4 million to €13.4 million (–66.7%), while UK imports collapsed from €7.3 million to just €0.4 million (–94.7%). The UK decline is almost certainly linked to the post-Brexit reconfiguration of trade flows, as the UK moved from being treated as an intra-EU partner to an extra-EU one, with associated customs and regulatory friction. The US decline, meanwhile, may reflect a combination of competitive displacement by Asian suppliers and strategic shifts by US chemical producers.

EU exports have shifted toward Switzerland and away from Israel and Brazil

On the export side, the EU's largest destination remains the United States (€53.5 million → €50.7 million, essentially stable). The most striking change is the surge in exports to Switzerland (€33.3 million → €58.1 million, +74.6%), which by 2025 had become the EU's top export market — driven in part by a dramatic price shock in 2023 with a +306% shift, representing 27.4% of export value (Volatility & Shocks). Conversely, exports to Israel collapsed from €17.3 million to €0.4 million (–97.5%), and exports to Brazil declined from €39.9 million to €22.6 million (–43.4%). These declines point to growing competition or shifting demand patterns in those markets.

Declining EU production and rising import vulnerability

EU production has shifted from volume to value

EU domestic production data for CN 2928 reveals a striking structural shift. Production quantity in kilograms fell from 300 million kg in 2015 to 200 million kg in 2025 (–33.3%), with a trough of just 180 million kg. Yet production value rose from €434.5 million to €800.0 million (+84.1%) (Market Structure). This divergence suggests that EU producers have moved up the value chain, focusing on higher-margin specialty derivatives rather than commodity-volume production. The unit production value thus more than tripled, from approximately €1.45/kg to €4.00/kg.

Net import reliance has surged to historically high levels

Perhaps the most consequential finding is the EU's sharply increased net import reliance. In 2015, the EU's net import reliance stood at a negligible 0.03%; by 2025, it had climbed to 19.4% (Autonomy & Vulnerability). The peak reached 38.4% during the period, indicating a phase of acute dependency. This shift reflects the combined effect of growing import volumes, declining export quantities, and reduced domestic production. For a product class used as an intermediate in pharmaceutical and agrochemical manufacturing, this level of external dependence raises supply-chain resilience questions.

The EU's export propensity has weakened while trade intensity has held steady

Export propensity — the share of EU production that is exported — declined from 30.5% to 24.7% (–19.0%), reinforcing the picture of a market that is increasingly oriented toward meeting domestic demand rather than competing internationally. Trade intensity, however, remained broadly stable at around 46–49%, indicating that the EU market for CN 2928 remains deeply integrated into global supply chains, even as the direction of that integration has shifted from net self-sufficiency toward import dependence.

Specialisation remains concentrated in a handful of Western European producers

Within the EU, production of CN 2928 is highly concentrated. The most specialised member states — as measured by revealed comparative advantage (RCA) — are Belgium (RCA: 2.72), Latvia (RCA: 2.61), France (RCA: 2.21), Spain (RCA: 2.10) and the Netherlands (RCA: 1.61) (Market Structure). By contrast, countries such as Luxembourg, Denmark, Cyprus, Slovakia and Romania show near-zero specialisation. On the import side, Germany (€111.6M → €134.7M) and Italy (€71.5M → €98.0M) are the largest importers within the EU, while the Netherlands saw the most dramatic growth (€20.3M → €54.8M, +169%).

Conclusion

Over the 2015–2025 period, the EU's trade in organic derivatives of hydrazine and hydroxylamine has undergone a fundamental transformation. The trade deficit has nearly doubled, driven by rising import volumes and a contraction in export quantities. The supplier landscape has been reshaped: India and China have gained ground as import sources, while the US and UK have receded. EU domestic production has pivoted toward higher-value output, but this has come at the cost of volume — contributing to a net import reliance that rose from near zero to nearly one-fifth of apparent consumption. Price volatility, particularly from Indian and Swiss sources, adds a further dimension of risk. For EU policymakers and industry stakeholders, these trends underscore the importance of monitoring supply-chain concentration and ensuring that the shift toward higher-value production does not leave the bloc vulnerable to external supply disruptions in a product class that serves as a critical input to key downstream industries.